Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans. 2017

Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
Universidad Autónoma de Chiapas, Facultad de Ciencias Químicas, Chiapas, Mexico.

BACKGROUND Infective endocarditis is a disease characterised by heart valve lesions, which exhibit extracellular matrix proteins that act as a physical barrier to prevent the passage of antimicrobial agents. The genus Candida has acquired clinical importance given that it is increasingly being isolated from cases of nosocomial infections. OBJECTIVE To evaluate the activity of caspofungin compared to that of liposomal amphotericin B against Candida albicans in experimental infective endocarditis. METHODS Wistar rats underwent surgical intervention and infection with strains of C. albicans to develop infective endocarditis. Three groups were formed: the first group was treated with caspofungin, the second with liposomal amphotericin B, and the third received a placebo. In vitro sensitivity was first determined to further evaluate the effect of these treatments on a rat experimental model of endocarditis by semiquantitative culture of fibrinous vegetations and histological analysis. RESULTS Our semiquantitative culture of growing vegetation showed massive C. albicans colonisation in rats without treatment, whereas rats treated with caspofungin showed significantly reduced colonisation, which was similar to the results obtained with liposomal amphotericin B. CONCLUSIONS The antifungal activity of caspofungin is similar to that of liposomal amphotericin B in an experimental model of infective endocarditis caused by C. albicans.

UI MeSH Term Description Entries
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004696 Endocarditis Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening. Infective Endocarditis,Endocarditides,Endocarditides, Infective,Endocarditis, Infective,Infective Endocarditides
D005260 Female Females
D000077336 Caspofungin A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES. Cancidas,Caspofungin Acetate,Caspofungin MSD,L 743,872,L 743872,L-743,872,L-743872,MK 0991,MK-0991,L743,872,L743872,MK0991
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
November 1980, Journal of the Reticuloendothelial Society,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
June 2022, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
January 1977, Acta chirurgica Iugoslavica,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
January 2007, Medicina intensiva,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
June 2006, Pharmacotherapy,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
November 2002, Antimicrobial agents and chemotherapy,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
March 2023, International journal of antimicrobial agents,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
September 2008, The Journal of antimicrobial chemotherapy,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
April 2004, The Pediatric infectious disease journal,
Gerardo Becerra Victorio, and Lorena Michele Brennan Bourdon, and Leonel García Benavides, and Selene G Huerta-Olvera, and Arturo Plascencia, and José Villanueva, and Erika Martinez-Lopez, and Iván Isidro Hernández-Cañaveral
October 2014, BMC infectious diseases,
Copied contents to your clipboard!